Market Commentary LIVE: Can Nifty Hold 24,000? Sudip Bandyopadhyay Explains

In this Business Today TV' Market Commentary episode, Market Expert Sudip Bandyopadhyay joins Shailendra Bhatnagar to decode the massive asset reallocation driving Indian equities heading into H2 2026. With global crude crashing nearly 19% in June and a recovering rupee backed by a projected $70–90 billion dollar inflow, Dalal Street faces strong macroeconomic tailwinds despite a 23% monsoon deficit. Bandyopadhyay shares a high-conviction structural playbook, detailing why Indian pharma is on the cusp of a multi-decade boom. He outlines top picks across the sector, including Sun Pharma, Divi's Labs, Mankind Pharma, and Apollo Hospitals. Conversely, he warns investors to strictly avoid traditional IT services due to structural AI disruptions, while spotlighting high-growth auto ancillaries like Samvardhana Motherson.